251 related articles for article (PubMed ID: 30240776)
1. Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr virus positivity and its effects on clinicopathologic features.
Lee WJ; Won KH; Choi JW; Won CH; Chang SE; Choi JH; Lee MW
J Am Acad Dermatol; 2019 Oct; 81(4):989-997. PubMed ID: 30240776
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous lesions of angioimmunoblastic T-cell lymphoma: Clinical, pathological, and immunophenotypic features.
Oishi N; Sartori-Valinotti JC; Bennani NN; Wada DA; He R; Cappel MA; Feldman AL
J Cutan Pathol; 2019 Sep; 46(9):637-644. PubMed ID: 30980412
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
Brown HA; Macon WR; Kurtin PJ; Gibson LE
J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
[TBL] [Abstract][Full Text] [Related]
4. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.
Eladl AE; Shimada K; Suzuki Y; Takahara T; Kato S; Kohno K; Elsayed AA; Wu CC; Tokunaga T; Kinoshita T; Sakata-Yanagimoto M; Nakamura S; Satou A
Cancer Med; 2020 Jan; 9(2):678-688. PubMed ID: 31793218
[TBL] [Abstract][Full Text] [Related]
5. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
Yang QX; Pei XJ; Tian XY; Li Y; Li Z
Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas.
Chen YP; Jones D; Chen TY; Chang KC
Leuk Lymphoma; 2014 Sep; 55(9):2038-47. PubMed ID: 24180328
[TBL] [Abstract][Full Text] [Related]
8. Intravascular large cell lymphoma of NK/T-cell type, EBV positive.
Okonkwo L; Jaffe ES
Blood; 2017 Aug; 130(6):837. PubMed ID: 28798060
[No Abstract] [Full Text] [Related]
9. Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma.
Poon F; Ieremia E; Collins G; Matin RN
Am J Dermatopathol; 2019 Dec; 41(12):927-930. PubMed ID: 31599749
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathological characteristics of C-MYC protein in angioimmunoblastic T-cell lymphoma.
Peng Y; Yan H; Wang J; Zhang M; He J
Acta Biochim Pol; 2022 Jul; 69(3):559-565. PubMed ID: 35878052
[TBL] [Abstract][Full Text] [Related]
11. [Expression and Clinical Pathological Significance of EBER, PTEN and VEGF in Angioimmunoblastic T-Cell Lymphoma].
Wang F; Zhang GH; Ding KY; Liu L; Weng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):663-8. PubMed ID: 26117013
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH.
Liang JH; Lu L; Zhu HY; Li W; Fan L; Li JY; Xu W
Cancer Res Treat; 2019 Jan; 51(1):150-157. PubMed ID: 29621877
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
Su IJ; Tsai TF; Cheng AL; Chen CC
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):685-92. PubMed ID: 8227539
[TBL] [Abstract][Full Text] [Related]
15. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression.
Attygalle AD; Kyriakou C; Dupuis J; Grogg KL; Diss TC; Wotherspoon AC; Chuang SS; Cabeçadas J; Isaacson PG; Du MQ; Gaulard P; Dogan A
Am J Surg Pathol; 2007 Jul; 31(7):1077-88. PubMed ID: 17592275
[TBL] [Abstract][Full Text] [Related]
16. [Epstein-Barr virus research by in situ hybridization in 65 cutaneous T cell epidermotropic lymphomas].
Jumbou O; Huet S; Bureau B; Litoux P; Dréno B
Ann Dermatol Venereol; 1998 Feb; 125(2):90-3. PubMed ID: 9747220
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cutaneous angioimmunoblastic T-cell lymphoma.
Balaraman B; Conley JA; Sheinbein DM
J Am Acad Dermatol; 2011 Oct; 65(4):855-862. PubMed ID: 21550134
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics.
Botros N; Cerroni L; Shawwa A; Green PJ; Greer W; Pasternak S; Walsh NM
Am J Dermatopathol; 2015 Apr; 37(4):274-83. PubMed ID: 25794369
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features.
Beaty MW; Toro J; Sorbara L; Stern JB; Pittaluga S; Raffeld M; Wilson WH; Jaffe ES
Am J Surg Pathol; 2001 Sep; 25(9):1111-20. PubMed ID: 11688570
[TBL] [Abstract][Full Text] [Related]
20. [Subcutaneous panniculitis-like T-cell lymphoma: expression of cytotoxic-granule-associated protein TIA-1 and its relation with Epstein-Barr virus infection].
Wang L; Yang Y; Liu W; Li G; Liao Q; Lai R; Li F; Ran Y; Zhou G
Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):103-6. PubMed ID: 11866900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
